Facts
The French Triathlon Federation (Fédération Française de Triathlon, FFTri) charges respondent M59 for a violation of the Anti-Doping Rules. During an athletics event on May 19, 2007, a sample was taken for doping test purposes.
History
The respondent had mentioned the use of a pharmaceutical product on the doping control form, she was using it for a therapeutic reason. There was no intention to enhance sport performance. A Therapeutic Use Exemption (TUE) was delivered by the AFLD on July 4, 2007, to use the product for therapeutic purposes. It mentioned the method of administration and the inhalation dosage: two puffs before exercise or when needed, which seems consistent, given the statements of the respondent and the salbutamol concentration detected in the urine.
Decision
1. The respondent is acquitted.
2. The decision (warning) of the disciplinary committee dated September 4, 2007, is cancelled.
2. The present decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.
